Dachaigh › Glioblastoma › California › Los Angeles
Sgrùdaidhean clionaigeach Glioblastoma ann an Los Angeles, CA
Tha 24 sgrùdaidhean airson Glioblastoma a’ lorg phàirtichean aig làraichean ann agus timcheall air Los Angeles (taobh a-staigh mu 30 mìle). Fosglaidh sgrùdadh gus faicinn cò as urrainn pàirt a ghabhail agus mar a chuireas tu fios air an sgioba.
Teacsa sgrùdaidh oifigeil (Beurla)
A’ fastadh airson sgrùdadh an seo? Seall e aig mullach na duilleige seo — $99 airson 30 latha →
Sonocloud-9 in Association With Carboplatin Versus Standard-of-Care Chemotherapies (CCNU or TMZ) in Recurrent GBM
A’ fastadhÌre 3
- Kaiser Permanente, Los Angeles
- UCLA, Los Angeles
Beginning Radiation Immediately With GammaTile at GBM Excision Versus Standard of Care
A’ fastadhÌre 3
- Keck Medicine of USC, Los Angeles
Testing the Addition of an Anti-cancer Drug, Selinexor, to the Usual Chemotherapy Treatment (Temozolomide) for Brain Tumors That Have Returned After Previous Treatment
A’ fastadhÌre 1/2
- Los Angeles General Medical Center, Los Angeles
- USC / Norris Comprehensive Cancer Center, Los Angeles
A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma
A’ fastadhÌre 2/3
- Cedars Sinai - Samuel Oschin Comprehensive Cancer Institute, Los Angeles
Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII
A’ fastadhÌre 2
- Cedars-Sinai Medical Center, Los Angeles
A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations
A’ fastadhÌre 1/2
- Children's Hospital Los Angeles, Los Angeles
- University of California at Los Angeles, Los Angeles
Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
A’ fastadhÌre 1/2
- University of Southern California, Los Angeles
Trial of Anti-PD-1 Immunotherapy and Stereotactic Radiation in Patients With Recurrent Glioblastoma
A’ fastadhÌre 1/2
- Cedars-Sinai Medical Center, Los Angeles
ERAS-801 for the Treatment of Resectable and Progressive or Recurrent or Elderly Newly Diagnosed IDH Wildtype Grade IV Glioblastoma or Gliosarcoma With an EGFR Amplification or Mutation, ERAS801-SARG Trial
A’ fastadhÌre 1
- UCLA / Jonsson Comprehensive Cancer Center, Los Angeles
Temporally-Modulated Pulsed Radiation Therapy Versus Standard Radiation Therapy for the Treatment of Newly Diagnosed, IDH Wildtype, MGMT-Unmethylated Glioblastoma
A’ fastadhÌre 3
- USC / Norris Comprehensive Cancer Center, Los Angeles
A Study of PRMT5 Inhibitor BAY 3713372 in Participants With MTAP-deleted Solid Tumors
A’ fastadhÌre 1/2
- UCLA Health Bowyer Oncology Center, Los Angeles
Study of ABBV-637 or ABBV-155 With ERAS-801 for People With Glioblastoma
A’ fastadhÌre 1
- University of California, Los Angeles (Data Collection Only), Los Angeles
SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
A’ fastadhÌre 3
- University of California, Los Angeles, Los Angeles
Identifying Findings on Brain Scans That Could Help Make Better Predictions About Brain Cancer Progression, The GABLE Trial
A’ fastadhÌre 2
- Cedars-Sinai Medical Center, Los Angeles
A Phase 2 Study of the Ketogenic Diet vs Standard Anti-cancer Diet Guidance for Patients With Glioblastoma in Combination With Standard-of-care Treatment
A’ fastadhÌre 2
- Cedars-Sinai Medical Center, Los Angeles
A Trial of RSC-1255 for Treatment of Patients With Advanced Malignancies
A’ fastadhÌre 1
- University of California, Los Angeles (UCLA) Department of Medicine - Hematology/Oncology, Los Angeles
PH Sensitive MRI Based Resections of Glioblastoma
A’ fastadhÌre 1
- Ronald Reagan Medical Center, Los Angeles
Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
A’ fastadh
- Oncology Institute for Hope and Innovation, Los Angeles
Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
A’ fastadhÌre 1/2
- University of California Los Angeles, Los Angeles
Advanced Imaging Techniques for Evaluating the Tumor Immune Microenvironment in Glioblastoma Patients
A’ fastadhÌre 3
- UCLA / Jonsson Comprehensive Cancer Center, Los Angeles
Magnetic Resonance Imaging for Improving Knowledge of Brain Tumor Biology in Patients With Resectable Glioblastoma
A’ fastadh
- UCLA / Jonsson Comprehensive Cancer Center, Los Angeles
Biologic Association Between Metabolic Magnetic Resonance-positron Emission Tomograph (MR-PET) and Tissue Measures of Glycolysis in Brain Tumors of Infiltrating Glioblastoma Cells
A’ fastadhÌre 1/2
- University of California at Los Angeles, Los Angeles
A Study to Evaluate TROP2 ADC LCB84 Single Agent and in Combination With an Anti-PD-1 Ab in Advanced Solid Tumors
A’ fastadhÌre 1/2
- Cedars Sinai Medical Center, Los Angeles
APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors
A’ fastadhÌre 2
- Cedars-Sinai Medical Center - Samuel Oschin Comprehensive Cancer Institute, Los Angeles
Sgrùdaidhean Glioblastoma ann am bailtean eile
- New York City, NY30 sgrùdaidhean
- Boston, MA28 sgrùdaidhean
- Houston, TX26 sgrùdaidhean
- Durham, NC20 sgrùdaidhean
- San Francisco, CA17 sgrùdaidhean
- Chicago, IL15 sgrùdaidhean
- Washington, DC15 sgrùdaidhean
- Columbus, OH14 sgrùdaidhean
- Miami, FL14 sgrùdaidhean
- Rochester, MN13 sgrùdaidhean
- Jacksonville, FL13 sgrùdaidhean
- Aurora, CO12 sgrùdaidhean
Sgrùdaidhean eile ann an Los Angeles
- Aillse Sgamhain Neo-chealla-beag87 sgrùdaidhean
- Aillse (gach seòrsa)74 sgrùdaidhean
- Aillse a' bhroilleach73 sgrùdaidhean
- Aillse Prostata61 sgrùdaidhean
- Aillse colorectal59 sgrùdaidhean
- Ailse metastatach57 sgrùdaidhean
- Cancer Ovarian50 sgrùdaidhean
- Ailseachadh nan Sgamhan45 sgrùdaidhean
- Carcinoma Cealla Sgamach a' Chinn agus a' Mhuineil42 sgrùdaidhean
- Cancer Pancreatic35 sgrùdaidhean
- Ailse Endometrial34 sgrùdaidhean
- Melanoma34 sgrùdaidhean
Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.